MR Spectroscopy and Serial Magnetic Resonance Imaging in a Patient with Mitochondrial Cystic Leukoencephalopathy due to Complex I Deficiency and NDUFV1 Mutations and Mild Clinical Course

Abstract

We present clinical, magnetic resonance imaging and MR spectroscopic findings of a female patient, first admitted at the age of 9 months for regression of motor milestones and signs of mild spastic diplegia. Magnetic resonance imaging (MRI) demonstrated periventricular white matter abnormalities with sparing of the subcortical white matter. Subsequent MRIs, performed at the ages of 13 and 16 months, demonstrated progression of the white matter changes, progressive white matter rarefaction and cystic degeneration, and additional involvement of the corpus callosum; only the subcortical white matter remained spared. Proton MR spectroscopy revealed lactate elevation in the white matter. Blood lactate and lactate/pyruvate ratio were mildly elevated. Subsequent analysis of mitochondrial function in muscle tissue showed decreases in substrate oxidation and in ATP and CrP production rates. Complex I activity was seriously decreased, whereas mild decreases of complex II and IV activities were also noted. Analysis of the NDUFV1 gene revealed compound heterozygosity for two point mutations, each of them carried by one parent. The further clinical course of the patient was uphill; she slowly regained all previously lost motor milestones. In conclusion, diffuse white matter changes on MRI are compatible with mitochondrial encephalopathy and not necessarily associated with a severe clinical course.

Key words

mitochondrial - leukoencephalopathy - complex I deficiency - NDUFV1 mutation - nuclear gene

References

• 1 Bénit P, Chretien D, Kadhom N. et al . Large-scale deletion and point mutations of the nuclear NDUFV1 and NDUFS1 genes in mitochondrial complex I deficiency.  Am J Hum Genet. 2001;  68 1344-1352
• 2 Bianchi MC, Sgandurra G, Tosetti M. et al . Brain magnetic resonance in the diagnostic evaluation of mitochondrial encephalopathies.  Biosci Rep. 2007;  27 69-85
• 3 Brockmann K, Bjornstad A, Dechent P. et al . Succinate in dystrophic white matter: a proton magnetic resonance spectroscopy finding characteristic for complex II deficiency.  Ann Neurol. 2002;  52 38-46
• 4 Bugiani M, Invernizzi F, Alberio S. et al . Clinical and molecular findings in children with complex I deficiency.  Biochim Biophys Acta. 2004;  1659 136-147
• 5 Darin N, Moslemi AR, Lebon S. et al . Genotypes and clinical phenotypes in children with cytochrome-c oxidase deficiency.  Neuropediatrics. 2003;  34 311-317
• 6 Janssen R, Nijtmans L, Heuvel L van den. et al . Mitochondrial complex I: Structure, function and pathology.  J Inherit Metab Dis. 2006;  29 499-515
• 7 Janssen AJ, Trijbels FJ, Sengers RC. et al . Measurement of the energy-generating capacity of human muscle mitochondria: diagnostic procedure and application to human pathology.  Clin Chem. 2006;  52 860-871
• 8 Schuelke M, Smeitink J, Mariman E. et al . Mutant NDUFV1 subunit of mitochondrial complex I causes leukodystrophy and myoclonic epilepsy.  Nat Genet. 1999;  21 260-261
• 9 Thornburn DR. Mitochondrial disorders: prevalence, myths and advances.  J Inherit Metab Dis. 2004;  27 349-362
• 10 Triepels RH, Heuvel LP Van Den, Trijbels JM. et al . Respiratory chain complex I deficiency.  Am J Med Genet. 2001;  106 37-45
• 11 Knaap MS van der, Pronk JC, Scheper GC. Vanishing white matter disease.  Lancet Neurol. 2006;  5 413-423

Correspondence